Publications

Register to Read

David Moss is the Paul Whiton Cherington Professor at Harvard Business School, where he teaches in the Business, Government, and the International Economy (BGIE) unit. He earned his B.A. from Cornell University and his Ph.D. from Yale. In 1992-1993, he served as a... View Details

Keywords: health care; health care; health care; health care; health care; health care; health care

December 2012 (Revised August 2013)
Case

Nestlé: Agricultural Material Sourcing Within the Concept of Creating Shared Value (CSV)

By: Ray A. Goldberg and Lorin A. Fries

Corporate Head of Agriculture Hans Jöhr's mind raced in anticipation of the executive board meeting that afternoon. Jöhr recognized the meeting as a key opportunity to strategize far into the future, reexamining how his team's efforts in sustainable agricultural... View Details

Keywords: Agribusiness; Value Creation; Quality; Supply Chain Management; Social Issues; Environmental Sustainability; Problems and Challenges; Growth and Development Strategy; Health Industry; Health Industry

Article

Drivers of the Variation in Prosthetic Implant Purchase Prices for Total Knee and Total Hip Arthroplasties

By: Derek A. Haas, Kevin J Bozic, Anthony M. DiGioia, Zirui Song and Robert S. Kaplan

Previous studies have documented wide variation in health-care spending and prices; however, the causes for the variation in supply purchase prices across providers are not well understood. The purpose of this study was to determine the drivers of variation in... View Details

Keywords: Costing; Cost Variation; Total Knee Arthroplasty; Total Hip Arthroplasty; Prosthetic Implant Cost; Health Care and Treatment; Cost Management; Health Industry; Health Industry

Read Now

November 2019 (Revised April 2021)
Technical Note

Rechargeable Batteries, 2017: Gigafactory Wars in the Offing?

By: John R. Wells and Benjamin Weinstock

In 2017, the global market for rechargeable lithium-ion (Li-ion) batteries was 126 gigawatt-hours (GWh) valued at $37 billion, growing by $10 billion in two years. Once confined largely to consumer electronics and appliances, the rapid increase in demand was spurred by... View Details

November 2005 (Revised November 2005)
Case

Massachusetts General Hospital and the Enbrel Royalty

By: David S. Scharfstein and Darren R. Smart

Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details

Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts

May 2017
Article

Behavioral Processes in Long-Lag Interventions

By: Dale T. Miller, Jennifer E. Dannals and Julian Zlatev

We argue that psychologists who conduct experiments with long lags between the manipulation and the outcome measure should pay more attention to behavioral processes that intervene between the manipulation and the outcome measure. Neglect of such processes, we contend,... View Details

Keywords: Field Experiments; Interventions; Behavioral Mediation; Theories Of Change; Longitudinal Studies; Behavior; Research; Change; Theory

Find at Harvard

February 2020
Supplement

Theranos: Who Has Blood on Their Hands? (B)

By: Nien-he Hsieh, Christina R. Wing and John Masko

This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details

Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States

Web

Faculty & Advisors | MBA

Faculty & Advisors MS/MBA Biotechnology: Life Sciences Faculty Amitabh Chandra, Ph.D. Henry and Allison McCance Professor of Business Administration at HBS, Ethel Zimmerman Winer Professor of Public Policy and Director of Health Policy... View Details

November 2009
Article

What Would Peter Say?

By: Rosabeth Moss Kanter

Heeding the wisdom of Peter Drucker might have helped us avoid - and will help us solve - numerous challenges, from restoring trust in business to tackling climate change. He issued early warnings about excessive executive pay, the auto industry's failure to adapt and... View Details

Keywords: Judgments; Employee Relationship Management; Leadership; Goals and Objectives; Management Practices and Processes; Organizational Change and Adaptation; Business and Community Relations; Business and Government Relations; Business and Shareholder Relations

Find at Harvard

16 Aug 2024
In Practice

Election 2024: What's at Stake for Business and the Workplace?

volunteer as poll workers. Facilitate political engagement. Look to online platforms that have simplified small contributions to political campaigns and increased the diversity of donors, as well as efforts to encourage employees and... View Details

Keywords: by Rachel Layne

September 2017
Case

Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry

By: Steven Rogers and Alyssa Haywoode

Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine... View Details

Keywords: Dr. Williams Carson; Otsuka America Pharmaceutical; Harvard; Abilify; Aripiprazole; Health Testing and Trials; Globalized Firms and Management; Globalized Markets and Industries; Cross-Cultural and Cross-Border Issues; Decision Choices and Conditions; Pharmaceutical Industry; Japan